{"id":"W3000712048","doi":"10.1016/j.jacc.2019.10.057","title":"Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome","year":2020,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":572,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian VIGOUR Centre; University of Toronto; St. Michael's Hospital; University of Alberta","funders":"American Regent; Esperion Therapeutics; Duke Clinical Research Institute; Astellas Pharma; Eisai; University of Toronto; Daiichi-Sankyo; Bayer HealthCare; European Commission; AstraZeneca; Amarin Corporation; Eli Lilly and Company; University of Alabama; Regeneron Pharmaceuticals; Boston VA Research Institute; Medicines Company; University of Alabama at Birmingham; Bristol-Myers Squibb; Cleveland Clinic; Novo Nordisk; MyoKardia; University of Pennsylvania; Belvoir Media Group; Servier; Gilead Sciences; York University; Pfizer; Heart and Stroke Foundation of Canada; HLS Therapeutics; GlaxoSmithKline; CSL Behring; Amgen; St. Jude Medical; Kowa Company; Sanofi; American Heart Association","keywords":"Medicine; Alirocumab; Acute coronary syndrome; Cardiology; Internal medicine; Lipoprotein(a); Lipoprotein; Cholesterol; Myocardial infarction","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001118973,0.0004530084,0.0007990299,0.0001974776,0.0002334847,0.000491968,0.0002211818,0.00048283,0.0009350632],"category_scores_gemma":[0.002514925,0.0001477542,0.0008498856,0.0002362603,0.0002267223,0.0002818771,0.000196702,0.0008627602,0.0001047403],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003690793,"about_ca_system_score_gemma":0.0003425492,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009402524,"about_ca_topic_score_gemma":0.001324479,"domain_scores_codex":[0.9994687,0.0002661546,0.0000614402,0.0000644935,0.00005992097,0.00007924178],"domain_scores_gemma":[0.9985994,0.0004756593,0.0004506109,0.00008743059,0.00008864335,0.0002983306],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5132532,0.01083319,0.2883247,0.001033752,0.008869653,0.0002699022,0.0001532589,0.001578353,0.008924949,0.0002317706,0.001598553,0.1649287],"study_design_scores_gemma":[0.04305618,0.07714142,0.8675881,0.0001546666,0.004712783,0.0003310116,0.00007694221,0.002526516,0.002009245,0.0003352528,0.002022166,0.00004563382],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9918898,0.006883585,0.00006657447,0.0002530756,0.00006503271,0.00004363084,0.00008339836,0.000008359668,0.0007065865],"genre_scores_gemma":[0.9983475,0.0009891286,0.00009309934,0.0001965194,0.00007070962,0.00002237894,0.00008942694,0.00000133775,0.000189881],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001118973,"threshold_uncertainty_score":0.005917788,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006028763705398898,"score_gpt":0.2373177668374906,"score_spread":0.2312890031320917,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}